Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sandy

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2016
Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, ZimbabweJ Z Metcalfe, S Makumbirofa, B Makamure, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2020
Preparing national tuberculosis control programmes for COVID-19C Sandy, K C Takarinda, C Timire, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2019
Local staff making sense of their tuberculosis data: key to quality care and ending tuberculosisE Heldal, R A Dlodlo, N Mlilo, et al.
Public Health Action|October 2, 2018
Has the utilisation of Xpert<sup>®</sup> MTB/RIF in Manicaland Province, Zimbabwe, improved with new guidance on whom to test?A Jokwiro, C Timire, A D Harries, et al.
Public Health Action|December 6, 2019
Targeted active screening for tuberculosis in Zimbabwe: are field digital chest X-ray ratings reliable?C Timire, C Sandy, M Ngwenya, et al.
Public Health Action|December 5, 2017
Age-stratified tuberculosis treatment outcomes in Zimbabwe: are we paying attention to the most vulnerable?R T Ncube, K C Takarinda, C Zishiri, et al.
Public Health Action|September 23, 2015
Does the type of treatment supporter influence tuberculosis treatment outcomes in Zimbabwe?N Mlilo, C Sandy, A D Harries, et al.
Public Health Action|July 1, 2016
Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in ZimbabweK Charambira, S Ade, A D Harries, et al.
American Heart Journal|March 26, 2023
Secondary analysis of electronic opt-out consent in pragmatic research: A study design method to diversify clinical trials?Prerna Gupta, Lisa C Sandy, Thomas J Glorioso, et al.
Public Health Action|August 17, 2019
A comparison of the yield and relative cost of active tuberculosis case-finding algorithms in ZimbabweS M Machekera, E Wilkinson, S G Hinderaker, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2016
Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, ZimbabweJ Z Metcalfe, S Makumbirofa, B Makamure, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2020
Preparing national tuberculosis control programmes for COVID-19C Sandy, K C Takarinda, C Timire, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2019
Local staff making sense of their tuberculosis data: key to quality care and ending tuberculosisE Heldal, R A Dlodlo, N Mlilo, et al.
Public Health Action|October 2, 2018
Has the utilisation of Xpert<sup>®</sup> MTB/RIF in Manicaland Province, Zimbabwe, improved with new guidance on whom to test?A Jokwiro, C Timire, A D Harries, et al.
Public Health Action|December 6, 2019
Targeted active screening for tuberculosis in Zimbabwe: are field digital chest X-ray ratings reliable?C Timire, C Sandy, M Ngwenya, et al.
Public Health Action|December 5, 2017
Age-stratified tuberculosis treatment outcomes in Zimbabwe: are we paying attention to the most vulnerable?R T Ncube, K C Takarinda, C Zishiri, et al.
Public Health Action|September 23, 2015
Does the type of treatment supporter influence tuberculosis treatment outcomes in Zimbabwe?N Mlilo, C Sandy, A D Harries, et al.
Public Health Action|July 1, 2016
Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in ZimbabweK Charambira, S Ade, A D Harries, et al.
American Heart Journal|March 26, 2023
Secondary analysis of electronic opt-out consent in pragmatic research: A study design method to diversify clinical trials?Prerna Gupta, Lisa C Sandy, Thomas J Glorioso, et al.
Public Health Action|August 17, 2019
A comparison of the yield and relative cost of active tuberculosis case-finding algorithms in ZimbabweS M Machekera, E Wilkinson, S G Hinderaker, et al.
Pageof 4